製品の概要

  • 製品名Anti-VEGF Receptor 3 antibody
    VEGF Receptor 3 一次抗体 製品一覧
  • 製品の詳細
    Mouse monoclonal to VEGF Receptor 3
  • アプリケーション適用あり: WB, ELISAmore details
  • 種交差性
    交差種: Human
    交差が予測される動物種: Rhesus monkey
  • 免疫原

    Recombinant fragment: ITEESHVIDT GDSLSISCRG QHPLEWAWPG AQEAPATGDK DSEDTGVVRD CEGTDARPYC KVLLLHEVHA NDTGSYVCYY KYIKARIEGT TAASSYVFVR, corresponding to amino acids 34-133 of Human VEGF Receptor 3 (NP_002011) with a proprietary tag.

  • ポジティブ・コントロール
    • MES-SA/Dx5 cell lysate. Partial tagged recombinant Human VEGF Receptor 3 (Immunogen).

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab89501 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB Use a concentration of 1 - 5 µg/ml. Predicted molecular weight: 146 kDa.
ELISA Use at an assay dependent dilution. Detection limit for recombinant tagged VEGF Receptor 3 is approximately 0.3ng/ml when used as a capture antibody.

ターゲット情報

  • 機能Receptor for VEGFC. Has a tyrosine-protein kinase activity.
  • 組織特異性Placenta, lung, heart, and kidney, does not seem to be expressed in pancreas and brain.
  • 関連疾患Defects in FLT4 are the cause of lymphedema hereditary type 1A (LMPH1A) [MIM:153100]; also known as Nonne-Milroy lymphedema or Milroy disease. Hereditary lymphedema is a chronic disabling condition which results in swelling of the extremities due to altered lymphatic flow. Patients with lymphedema suffer from recurrent local infections and physical impairment.
    Note=Defects in FLT4 are found in juvenile hemangioma. Juvenile hemangiomas are the most common tumors of infancy, occurring as many as 10% of all births. These benign vascular lesions enlarge rapidly during the first year of life by hyperplasia of endothelial cells and attendant pericytes, and then spontaneously involute over a period of years, leaving loose fibrofatty tissue.
  • 配列類似性Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
    Contains 7 Ig-like C2-type (immunoglobulin-like) domains.
    Contains 1 protein kinase domain.
  • 細胞内局在Membrane.
  • Information by UniProt
  • 参照データベース
  • 別名
    • EC 2.7.10.1 antibody
    • flt 4 antibody
    • FLT-4 antibody
    • FLT4 antibody
    • FLT41 antibody
    • Fms related tyrosine kinase 4 antibody
    • Fms-like tyrosine kinase 4 antibody
    • LMPH1A antibody
    • PCL antibody
    • Soluble VEGFR3 variant 1 antibody
    • Soluble VEGFR3 variant 2 antibody
    • Soluble VEGFR3 variant 3 antibody
    • Tyrosine protein kinase receptor FLT4 antibody
    • Tyrosine-protein kinase receptor FLT4 antibody
    • Vascular endothelial growth factor receptor 3 antibody
    • Vascular endothelial growth factor receptor 3 precursor antibody
    • VEGF R3 antibody
    • VEGFR 3 antibody
    • VEGFR-3 antibody
    • VEGFR3 antibody
    • VGFR3_HUMAN antibody
    see all

Anti-VEGF Receptor 3 antibody 画像

  • Anti-VEGF Receptor 3 antibody (ab89501) at 5 µg/ml + Partial tagged recombinant Human VEGF Receptor 3 protein at 0.2 µg

    Predicted band size : 146 kDa
    Observed band size : 37 kDa (why is the actual band size different from the predicted?)
  • Anti-VEGF Receptor 3 antibody (ab89501) at 5 µg/ml + MES-SA/Dx5 cell lysate at 50 µg

    Predicted band size : 146 kDa
    Observed band size : 155 kDa (why is the actual band size different from the predicted?)
  • Detection limit for recombinant tagged VEGF Receptor 3 is approximately 0.3ng/ml as a capture antibody.

Anti-VEGF Receptor 3 antibody (ab89501) 使用論文

ab89501 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab89501.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"